Progesterone organogel for premenstrual dysphoric disorder [5] (multiple letters)

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 39, Issue 5, 2000, Pages 546-547

  Horrigan, Joseph P ^b  

^a Departments of Obstetrics and Gynecology and Psychiatry   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; PROGESTERONE;

ADOLESCENT; ALLERGY; CASE REPORT; CLINICAL FEATURE; DRUG ABSORPTION; DRUG DESIGN; DRUG FORMULATION; DYSPHORIA; FEMALE; HAND; HORMONAL THERAPY; HUMAN; LETTER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034006932     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200005000-00006     Document Type: Letter

References (5)

1. E Freeman K Rickels SJ Sondheimer M Polansky Ineffectiveness of progesterone suppository treatment for premenstrual syndrome JAMA 264 1990 349 353
2. MD Majewska NJ Harrison RD Schwartz JL Barker SM Paul Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor Science 232 1986 1004 1007
3. M Steiner M Korzekwa J Lamont A Wilkins Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria Psychopharmacol Bull 33 1997 771 774
4. HA Van Leusden Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency Lancet 346 1995 1443 1444
5. KA Yonker Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? J Clin Psychiatry 58 suppl 3 1997 62 67